Yew Bio-Pharm Group, Inc. Operating Margin
- Operating margin · 12 months: Value 3.57%; Formula and calculation Operating income / revenue. Period ending 2021-09-30..
Operating margin
Overview →Financial period ending 2021-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 3.57% | Operating income / revenue. Period ending 2021-09-30. $1.04M ÷ $29.05M × 100 ≈ 3.57% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 1.04M USD | Operating Income (Loss) |
| Revenue | 29.05M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | (m) | Research and Development Expense |
| Selling, general and administration | 962.17K USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2021-09-30 | $1.04M | $29.05M | (m) | (m) | $962.17K | 3.57% |
| 2021-06-30 | $4.09M | $39.30M | (m) | (m) | $954.09K | 10.41% |
| 2021-03-31 | $5.38M | $34.02M | (m) | (m) | $981.22K | 15.81% |
| 2020-12-31 | $2.57M | $27.31M | (m) | (m) | $988.97K | 9.41% |
| 2020-09-30 | $765.89K | $25.08M | (m) | (m) | $981.85K | 3.05% |
| 2020-06-30 | (m) | $15.40M | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $18.40M | $10.02M | (m) | (m) | (m) |
| 2019-12-31 | (m) | $27.88M | $10.00M | $0.00 | (m) | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $114.39K | $43.82M | $11.00M | (m) | $1.05M | 0.26% |
| 2019-03-31 | $1.04M | $46.08M | $1.26M | (m) | $1.05M | 2.27% |
| 2018-12-31 | $718.60K | $37.60M | $1.24M | $0.00 | $1.02M | 1.91% |
| 2018-09-30 | $-4.18M | $37.39M | $8.68M | (m) | (m) | -11.17% |
| 2018-06-30 | $-4.90M | $34.91M | $8.55M | (m) | (m) | -14.04% |
| 2018-03-31 | $3.32M | $35.70M | $12.52M | (m) | (m) | 9.31% |
| 2017-12-31 | $3.32M | $40.54M | $17.81M | $0.00 | $1.03M | 8.20% |
| 2017-09-30 | $9.62M | $47.05M | $26.34M | (m) | (m) | 20.44% |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $1.27M | $50.60M | $29.36M | (m) | (m) | 2.50% |
| 2016-12-31 | $2.12M | $51.35M | $24.69M | $860.00 | (m) | 4.13% |
| 2016-09-30 | $4.82M | $56.61M | $22.38M | (m) | (m) | 8.51% |
| 2016-06-30 | $4.63M | $46.94M | $16.63M | (m) | (m) | 9.87% |
| 2016-03-31 | $5.22M | $35.55M | $11.36M | (m) | (m) | 14.68% |
| 2015-12-31 | $5.14M | $29.57M | $11.10M | $13.55K | (m) | 17.38% |
| 2015-09-30 | $4.43M | $14.20M | $4.38M | (m) | (m) | 31.20% |
| 2015-06-30 | $4.39M | $10.90M | $2.72M | (m) | (m) | 40.26% |
| 2015-03-31 | $3.91M | $8.30M | $1.54M | (m) | (m) | 47.11% |
| 2014-12-31 | $4.29M | $7.73M | $1.58M | $53.54K | (m) | 55.47% |
| 2014-09-30 | $4.73M | $7.82M | $1.65M | (m) | (m) | 60.42% |
| 2014-06-30 | $4.42M | $7.67M | $2.04M | (m) | (m) | 57.69% |
| 2014-03-31 | $4.33M | $7.71M | $1.89M | (m) | (m) | 56.17% |
| 2013-12-31 | $3.90M | $7.44M | $1.97M | $23.13K | (m) | 52.39% |
| 2013-09-30 | $1.70M | $7.34M | $1.69M | (m) | (m) | 23.17% |
| 2013-06-30 | $1.99M | $7.17M | $1.22M | (m) | (m) | 27.76% |
| 2013-03-31 | $2.12M | $6.97M | $1.31M | (m) | (m) | 30.41% |
| 2012-12-31 | $2.20M | $6.73M | $1.10M | $14.59K | (m) | 32.77% |
| 2012-09-30 | $4.55M | $6.38M | $776.88K | (m) | (m) | 71.40% |
| 2012-06-30 | $4.39M | $6.21M | $850.59K | (m) | (m) | 70.67% |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $4.05M | $5.96M | $741.51K | $16.05K | (m) | 67.89% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.